Issue 13, 2014

Tailor-made gemcitabine prodrug nanoparticles from well-defined drug–polymer amphiphiles prepared by controlled living radical polymerization for cancer chemotherapy

Abstract

The therapeutic efficacy of gemcitabine is severely compromised by its rapid plasma degradation and low tumor-targeting efficiency. Furthermore, the hydrophilic properties of gemcitabine also make efficient encapsulation and in vivo release of the compound difficult in a nanoscale drug delivery system. Herein, gemcitabine–poly(methyl methacrylate) (Gem–PMMA) conjugated amphiphiles were prepared from a gemcitabine-bearing trithiocarbonate initiator via reversible addition–fragmentation chain transfer (RAFT) polymerization. The prodrug conjugate with a high drug payload can self-assemble in water into nanoparticles with an average diameter of 130 nm. In addition, gemcitabine molecules within the Gem–PMMA nanoparticles mainly exist in an amorphous state, implicating better gemcitabine release. Indeed, the releasing kinetics of gemcitabine was pH-dependent and a controlled release of gemcitabine from the nanoparticles was observed with 71.6% of cumulative drug release in 72 h in the presence of protease cathepsin B. The cytotoxicity of the gemcitabine prodrug nanoparticles was evident as demonstrated by an in vitro viability assay using human pulmonary carcinoma, A549, and breast cancer cells, MCF-7. In vivo assessment of the gemcitabine-loaded nanoparticles using BALB/c nude mice with A549 cell derived xenograft tumors indicated that these intravenously administered nanoparticles efficiently inhibit tumor growth as well as alleviate the drug-associated side effects at a dose of 26 mg kg−1. In summary a prodrug nanoparticle, Gem–PMMA, with excellent delivery efficiency and tumor growth inhibition efficacy, was designed and produced. Our results demonstrated the potential of the gemcitabine prodrug nanoparticles as a promising therapeutic formulation for chemotherapy.

Graphical abstract: Tailor-made gemcitabine prodrug nanoparticles from well-defined drug–polymer amphiphiles prepared by controlled living radical polymerization for cancer chemotherapy

Associated articles

Supplementary files

Article information

Article type
Paper
Submitted
05 Nov 2013
Accepted
14 Jan 2014
First published
14 Jan 2014

J. Mater. Chem. B, 2014,2, 1891-1901

Author version available

Tailor-made gemcitabine prodrug nanoparticles from well-defined drug–polymer amphiphiles prepared by controlled living radical polymerization for cancer chemotherapy

W. Wang, C. Li, J. Zhang, A. Dong and D. Kong, J. Mater. Chem. B, 2014, 2, 1891 DOI: 10.1039/C3TB21558J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements